| IVGAX | VIVIX | IVGAX / VIVIX | |
| Total Expense Ratio | 1.24 | 0.04 | 3,100% |
| Annual Report Gross Expense Ratio | 1.24 | 0.04 | 3,100% |
| Fund Existence | 22 years | 27 years | - |
| Gain YTD | -9.011 | 11.991 | -75% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 158M | 208B | 0% |
| Annual Yield % from dividends | 2.83 | 2.10 | 135% |
| Returns for 1 year | -13.20 | 6.69 | -197% |
| Returns for 3 years | -5.18 | 33.49 | -15% |
| Returns for 5 years | 7.72 | 66.36 | 12% |
| Returns for 10 years | -11.46 | 134.98 | -8% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SHSCX | 52.18 | 0.50 | +0.97% |
| BlackRock Health Sciences Opps Inv C | |||
| EKBYX | 16.42 | 0.09 | +0.55% |
| Allspring Diversified Cap Bldr Inst | |||
| CLSYX | 23.10 | 0.11 | +0.48% |
| Columbia International Div Inc Inst3 | |||
| CNZLX | 12.56 | 0.03 | +0.24% |
| Commonwealth Australia/New Zealand | |||
| IJPMX | 13.48 | 0.03 | +0.22% |
| VY® JPMorgan Mid Cap Value S2 | |||